Insulin, a hormone produced by the pancreas, plays a pivotal role in regulating blood sugar levels and facilitating glucose uptake into cells for energy production. By regulating how the body utilizes carbohydrates, fats, and proteins, insulin is a key player in metabolic processes.
Understanding insulin is crucial for maintaining overall health as well as preventing and treating metabolic disorders such as diabetes. This article provides an in-depth exploration of insulin, covering its function, production, testing methods, and clinical significance.
Additionally, it delves into insulin resistance, a condition where cells become less responsive to insulin, and offers insights into strategies for managing insulin levels and improving insulin sensitivity for optimal health.
Insulin, a peptide hormone, is produced by the beta cells of the pancreas and serves as a fundamental regulator of glucose metabolism in the body. Structurally, insulin consists of two polypeptide chains, an A chain comprising 21 amino acids and a longer B chain comprising 30 amino acids, connected by disulfide bonds.
Insulin plays a central role in the uptake and storage of glucose in cells, promoting the conversion of glucose into glycogen in the liver and muscle tissue for short-term energy storage.
Additionally, insulin facilitates the uptake of glucose by various tissues, including muscle and fat cells, thereby regulating blood sugar levels and preventing hyperglycemia.
Beyond glucose metabolism, insulin also influences lipid and protein metabolism, serving as a key orchestrator of metabolic processes essential for maintaining energy balance and overall metabolic homeostasis in the body.
Insulin is primarily produced in the beta cells of the pancreas, which are located in small clusters called islets of Langerhans. These islets are scattered throughout the pancreas and contain various cell types, with beta cells being responsible for synthesizing and secreting insulin.
When blood glucose levels rise, beta cells sense this increase and respond by releasing insulin into the bloodstream. Insulin then travels to target tissues throughout the body, where it plays a crucial role in regulating glucose metabolism and promoting glucose uptake by cells, thereby maintaining optimal blood sugar levels.
Insulin secretion is tightly regulated by various factors including blood glucose concentration, hormones, neural inputs, and nutrient availability, to ensure precise control of glucose homeostasis.
The synthesis of insulin begins with the transcription of the insulin gene (INS) into messenger RNA (mRNA) within the nucleus of the beta cells, in the Isles of Langerhans. This mRNA is then translated into preproinsulin, a single polypeptide chain consisting of the insulin A and B chains, along with a connecting peptide called the C-peptide.
Preproinsulin undergoes post-translational modifications, including removal of the signal sequence, to form proinsulin. Within the endoplasmic reticulum, proinsulin is folded and assembled into its three-dimensional structure.
Further processing in the Golgi apparatus involves cleavage of the C-peptide, yielding mature insulin composed of the A and B chains connected by disulfide bonds.
Insulin is then stored in secretory granules until it is released into the bloodstream in response to elevated blood glucose levels or other stimuli, such as amino acids or gastrointestinal hormones, to regulate glucose metabolism and maintain metabolic balance throughout the body.
Insulin has various functions throughout the body, with many implications for health or chronic disease. Several of insulin’s essential functions in regulating blood sugar levels occur in the liver, in adipocytes or fat cells, in brain cells and in muscles.
Upon secretion from pancreatic beta cells in response to elevated blood glucose levels, insulin binds to specific receptors on target cells, initiating a cascade of cellular events.
In the liver, insulin promotes the uptake and storage of glucose as glycogen, a process known as glycogenesis. Additionally, insulin inhibits gluconeogenesis, the synthesis of glucose from non-carbohydrate sources, thereby further reducing blood glucose levels.
In peripheral cells like muscle and adipose tissue, insulin facilitates the uptake of glucose from the bloodstream, promoting its utilization for energy production or storage as glycogen and triglycerides. This process helps to lower blood glucose levels and provides cells with the necessary energy for various metabolic functions.
Furthermore, insulin exerts important effects in the brain, where it contributes to neuronal glucose uptake and metabolism, supporting proper brain function and cognition. Additionally, insulin regulates appetite control in the brain.
Overall, insulin acts as a key regulator of glucose homeostasis, ensuring that cells receive an adequate supply of glucose for energy production while preventing hyperglycemia.
Insulin resistance is a condition in which cells in the body become less responsive to the effects of insulin, leading to impaired glucose uptake and utilization.
Normally, insulin helps regulate blood sugar levels by facilitating the entry of glucose into cells, where it can be used for energy production or stored for later use. However, in insulin resistance, cells become resistant to insulin's actions, resulting in elevated blood sugar levels and compensatory increases in insulin secretion by the pancreas.
Insulin plays a critical role in liver and adipose tissue function, and these relationships have many implications for metabolic health.
In insulin resistance, the liver's response to insulin becomes impaired, leading to increased production of glucose through a process known as gluconeogenesis. Additionally, insulin normally inhibits the breakdown of stored glycogen into glucose in the liver, but in insulin resistance, this inhibition is blunted, further contributing to elevated blood sugar levels.
Moreover, insulin resistance in the liver can lead to increased synthesis of triglycerides and decreased clearance of circulating fatty acids, promoting the development of non-alcoholic fatty liver disease (NAFLD) and potentially progressing to more severe liver conditions like non-alcoholic steatohepatitis (NASH).
In insulin resistance, adipose tissue undergoes significant changes in both structure and function. Adipocytes, or fat cells, become larger as they accumulate more triglycerides due to impaired insulin signaling, leading to the enlargement of fat depots.
Insulin resistance also alters the secretion of adipokines, adipose-derived hormones involved in metabolic regulation, contributing to chronic low-grade inflammation and metabolic dysfunction. [10.]
These changes in fat cell structure and function contribute to systemic insulin resistance and are implicated in the pathogenesis of obesity-related complications such as type 2 diabetes, cardiovascular disease, and metabolic syndrome.
Insulin resistance co-occurs with rising levels of blood sugar over time; therefore, identifying insulin resistance and implementing strategies to lower blood sugar levels and reverse insulin resistance are essential for health.
Insulin resistance is often associated with obesity, physical inactivity, unhealthy diet, genetics, and aging, and it is a key component of metabolic syndrome.
Insulin resistance arises from a complex interplay of genetic, environmental, and lifestyle factors. Genetic predisposition plays a significant role, with certain genetic variants contributing to impaired insulin signaling pathways or altered expression of insulin-responsive genes. [4.]
Obesity, particularly visceral adiposity, is strongly associated with insulin resistance, as excess adipose tissue releases pro-inflammatory cytokines and adipokines that interfere with insulin action. [10.]
Obesity and insulin resistance are driven by dietary factors including high intake of refined carbohydrates, saturated fats, and sugar-sweetened beverages. [2., 14.] These can induce insulin resistance by promoting adiposity and ectopic fat deposition, leading to lipid accumulation in non-adipose tissues like the liver and skeletal muscle.
Sedentary behavior and physical inactivity further exacerbate insulin resistance by reducing muscle glucose uptake and impairing mitochondrial function. [11.]
Chronic stress and sleep disturbances also contribute to insulin resistance through dysregulation of the hypothalamic-pituitary-adrenal axis and sympathetic nervous system activity, which ultimately promotes gluconeogenesis and glycogenolysis to raise blood sugar levels. [15.]
Overall, insulin resistance is a multifactorial condition influenced by a combination of genetic, metabolic, and lifestyle factors.
The first step in reversing insulin resistance is undergoing testing to determine an individual’s insulin levels and degree of insulin resistance. A fasting insulin test is an important piece of information, especially in conjunction with other parameters of health including:
Other tests are available to assess for insulin resistance, although they are less commonly employed in a clinical setting.
Blood testing for insulin levels involves obtaining a blood sample, typically through venipuncture, to measure the concentration of insulin circulating in the bloodstream. This test is often done as a fasting test.
Blood insulin levels are typically measured in conjunction with glucose levels to evaluate the insulin-glucose relationship and assess overall metabolic health. While blood testing for insulin levels is widely available and commonly used in research and clinical settings, it may not always reflect tissue-specific insulin action or provide a comprehensive assessment of insulin dynamics. Therefore, insulin testing as part of a more comprehensive assessment is generally preferred. [9.]
The fasting insulin test is a specific blood test used to measure insulin levels after an overnight fast, typically for 8-12 hours. This test provides insights into basal insulin secretion and fasting insulin sensitivity, offering valuable information about insulin resistance and metabolic health.
Fasting insulin levels are often interpreted alongside fasting glucose levels to assess the insulin-glucose relationship and evaluate overall metabolic function. While fasting insulin testing is a valuable tool in diagnosing and managing insulin-related disorders such as insulin resistance and type 2 diabetes, it may not capture postprandial insulin dynamics or provide a complete picture of insulin secretion throughout the day.
Insulin testing plays a crucial role in both health optimization and diabetes management by providing valuable insights into insulin secretion, sensitivity, and action. For individuals without diabetes, assessing insulin levels can help identify early signs of insulin resistance and metabolic dysfunction, allowing for proactive intervention through lifestyle modifications and targeted therapies.
Different models are available to assess insulin sensitivity and resistance in a clinical setting. Two often-used models are the HOMA-IR and the QUICKI.
The Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) is a mathematical formula used to estimate insulin resistance by measuring fasting blood glucose and insulin levels. It provides a practical and cost-effective method for assessing insulin resistance, with higher HOMA-IR values indicating greater insulin resistance. [9.]
The Quantitative Insulin Sensitivity Check Index (QUICKI) is another method to assess insulin sensitivity, calculated using fasting insulin and glucose levels. A lower QUICKI value suggests higher insulin resistance, while a higher value indicates better insulin sensitivity. [9.]
In diabetes management, insulin testing is used to monitor insulin therapy effectiveness, evaluate insulin resistance, and guide treatment decisions.
By measuring insulin levels and understanding insulin dynamics, healthcare providers can tailor treatment strategies to optimize metabolic health and improve diabetes outcomes. Overall, insulin testing serves as a valuable tool in promoting health and managing metabolic disorders, contributing to personalized and effective patient care.
Lowering baseline, or fasting, insulin levels, increasing the body’s utilization of glucose, and possibly creating a negative energy balance are necessary steps in reversing the metabolic dysfunction of insulin resistance. To do this, lifestyle modifications and dietary changes are essential. [1.]
One effective approach is to adopt a low-carbohydrate diet that limits the intake of refined sugars and starches, as these foods can cause spikes in blood sugar and subsequently increase insulin production. [8.]
Incorporating more fiber-rich foods like vegetables, legumes, and whole grains can help slow down the absorption of carbohydrates and stabilize blood sugar levels, thereby reducing the need for insulin secretion. [7., 12.]
Regular exercise is also beneficial, as physical activity helps improve insulin sensitivity and promotes glucose uptake by muscle cells, lowering the overall demand for insulin. [BIRD]
Managing stress levels through techniques such as meditation, yoga, and deep breathing exercises can help reduce cortisol levels, which in turn can improve insulin sensitivity and lower insulin production. [15.]
Ensuring adequate and quality sleep is also essential for regulating insulin levels. Sleep deprivation can disrupt the body's hormone balance, leading to insulin resistance and increased insulin production. Prioritizing a consistent sleep schedule and practicing good sleep hygiene habits can support optimal insulin sensitivity and metabolic health. [13.]
[1.] Assali AR, Ganor A, Beigel Y, Shafer Z, Hershcovici T, Fainaru M. Insulin resistance in obesity: body-weight or energy balance? J Endocrinol. 2001 Nov;171(2):293-8. doi: 10.1677/joe.0.1710293. PMID: 11691649.
[2.] Beck–Nielsen H, Pedersen O, Lindskov HO. Impaired cellular insulin binding and insulin sensitivity induced by high–fructose feeding in normal subjects. The American journal of clinical nutrition. 1980;33:273–8.
[3.] Bird SR, Hawley JA. Update on the effects of physical activity on insulin sensitivity in humans. BMJ Open Sport Exerc Med. 2017 Mar 1;2(1):e000143. doi: 10.1136/bmjsem-2016-000143. PMID: 28879026; PMCID: PMC5569266.
[4.] Brown AE, Walker M. Genetics of Insulin Resistance and the Metabolic Syndrome. Curr Cardiol Rep. 2016 Aug;18(8):75. doi: 10.1007/s11886-016-0755-4. PMID: 27312935; PMCID: PMC4911377.
[5.] Chen ZW, Chen LY, Dai HL, Chen JH, Fang LZ. Relationship between alanine aminotransferase levels and metabolic syndrome in nonalcoholic fatty liver disease. J Zhejiang Univ Sci B. 2008 Aug;9(8):616-22. doi: 10.1631/jzus.B0720016. PMID: 18763311; PMCID: PMC2491691.
[6.] DiNicolantonio JJ, O'Keefe JH. Added Sugars Drive Insulin Resistance, Hyperinsulinemia, Hypertension, Type 2 Diabetes and Coronary Heart Disease. Mo Med. 2022 Nov-Dec;119(6):519-523. PMID: 36588634; PMCID: PMC9762218.
[7.] Foley PJ. Effect of low carbohydrate diets on insulin resistance and the metabolic syndrome. Curr Opin Endocrinol Diabetes Obes. 2021 Oct 1;28(5):463-468. doi: 10.1097/MED.0000000000000659. PMID: 34468401; PMCID: PMC8500369.
[8.] Goldenberg JZ, Day A, Brinkworth GD, Sato J, Yamada S, Jönsson T, Beardsley J, Johnson JA, Thabane L, Johnston BC. Efficacy and safety of low and very low carbohydrate diets for type 2 diabetes remission: systematic review and meta-analysis of published and unpublished randomized trial data. BMJ. 2021 Jan 13;372:m4743. doi: 10.1136/bmj.m4743. PMID: 33441384; PMCID: PMC7804828.
[9.] Gutch M, Kumar S, Razi SM, Gupta KK, Gupta A. Assessment of insulin sensitivity/resistance. Indian J Endocrinol Metab. 2015 Jan-Feb;19(1):160-4. doi: 10.4103/2230-8210.146874. PMID: 25593845; PMCID: PMC4287763.
[10.] Kwon H, Pessin JE. Adipokines mediate inflammation and insulin resistance. Front Endocrinol (Lausanne). 2013 Jun 12;4:71. doi: 10.3389/fendo.2013.00071. PMID: 23781214; PMCID: PMC3679475.
[11.] Lin Y, Fan R, Hao Z, et al. The Association Between Physical Activity and Insulin Level Under Different Levels of Lipid Indices and Serum Uric Acid. Frontiers in Physiology. 2022;13. doi:https://doi.org/10.3389/fphys.2022.809669
[12.] McMacken M, Shah S. A plant-based diet for the prevention and treatment of type 2 diabetes. J Geriatr Cardiol. 2017 May;14(5):342-354. doi: 10.11909/j.issn.1671-5411.2017.05.009. PMID: 28630614; PMCID: PMC5466941.
[13.] Mesarwi O, Polak J, Jun J, Polotsky VY. Sleep disorders and the development of insulin resistance and obesity. Endocrinol Metab Clin North Am. 2013 Sep;42(3):617-34. doi: 10.1016/j.ecl.2013.05.001. PMID: 24011890; PMCID: PMC3767932.
[14.] Pagliassotti MJ, Shahrokhi KA, Moscarello M. Involvement of liver and skeletal muscle in sucrose–induced insulin resistance: dose–response studies. The American journal of physiology. 1994;266:R1637–44.
[15.] Sharma K, Akre S, Chakole S, Wanjari MB. Stress-Induced Diabetes: A Review. Cureus. 2022 Sep 13;14(9):e29142. doi: 10.7759/cureus.29142. PMID: 36258973; PMCID: PMC9561544.
[16.] Thota S, Akbar A. Insulin. [Updated 2023 Jul 10]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK560688/